AAPL
64
3
CLX
65
2
OKE
61
2
AA
27
5
UNP
38
5
STT
48
4
SYF
78
7
NTRS
35
10
TROW
37
8
VMC
41
2
DNB
72
4
NOV
45
2
BDX
59
3
BK
60
2
AXP
63
3
PSA
43
6
NDAQ
46
2
CSCO
63
5
KLAC
45
3
TGNA
48
5
AAPL
64
3
CLX
65
2
OKE
61
2
AA
27
5
UNP
38
5
STT
48
4
SYF
78
7
NTRS
35
10
TROW
37
8
VMC
41
2
DNB
72
4
NOV
45
2
BDX
59
3
BK
60
2
AXP
63
3
PSA
43
6
NDAQ
46
2
CSCO
63
5
KLAC
45
3
TGNA
48
5
Financhill
Back

Biodexa Pharmaceuticals PLC 10K Form

Sell
26

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
$3.93
Seasonality Move:
-9.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.1K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.21

Profitability

EPS (TTM): -74.59720
Net Income (TTM): $-8.5M
Gross Margin: $-4.6M
Return on Equity: 0%
Return on Assets: 0%

Biodexa Pharmaceuticals PLC Earnings Forecast

Key Biodexa Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Biodexa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
26
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy or a Sell?